Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Baird Maintains Outperform on Oracle, Lowers Price Target to $315

Author: Benzinga Newsdesk | November 18, 2025 11:02am
Baird analyst Rob Oliver maintains Oracle (NYSE:ORCL) with a Outperform and lowers the price target from $365 to $315.

Posted In: ORCL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist